Bristol-Myers Squibb Co in Consumer Health (Cameroon)

January 2017 | 2 pages | ID: BD1378C2F62EN
Euromonitor International Ltd

Abstracts

Bristol-Myers Squibb’s strategy uniquely combines the reach and resources of a major pharma company with the entrepreneurial spirit and agility of a successful biotech company. The player is determined to keep introducing new medicines from its pipeline: the company is investigating Prostvac as an anti-cancer treatment. Its focus is on patients’ needs, giving maximum priority to accelerating pipeline development, delivering sales growth and continuing to manage costs.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.


Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
  Summary 1 Bristol-Myers Squibb Co: Key Facts
  Summary 2 Bristol-Myers Squibb Co: Operational Indicators
Competitive Positioning
  Summary 3 Bristol-Myers Squibb Co: Competitive Position 2016